Q1FY22 Earnings Presentation

8 Strides Acquisition of ANDA portfolio from Endo solves for headwinds Portfolio more than doubles our current basket of 100 approved ANDA's Strides will pay ~US$24m for the acquisition of basket of ANDAs and the manufacturing facility at Chestnut Ridge, NY . Transaction Details • The transaction will be financed by a combination of internal accruals and debt financing 1 Adjusting for overlapping products, our portfolio of 100 approved products will more than double with the acquired basket 2 20 commercialized products will transition from Endo to Strides on closing and along with a basket of commercializable ANDAS (IQVIA MAT US$4.7bn). . The transaction is expected to close in 60-70 days subject to customary closing conditions Acquired Portfolio + Immediately Accretive Accelerate product launches in the US with 5-6 new product introductions each quarter from the acquired portfolio solving for its current dry run of key approvals from our filings Scale of the combined portfolio helps us refocus R&D spends to more complex and specialty programs 1 2 3 Differentiated portfolio comprising of Controlled Substances, Hormones, Nasal Sprays, Gels, Modified Release products, Liquids. 3 Transaction delivers over 100 TAA compliant ANDAs allowing us to broad base our offering to federal procurements 4 Significantly expands our middle of pyramid product basket enabling sustainability of margins 4 Readily available basket ensures lower dependency on new ANDA filings and approvals 5 Mitigates delays in approvals due to Covid-19 induced travel restrictions and delay in inspections 5 Leverage IP to expand our product offering for the global markets through portfolio maximization 60 Despite impact in Q1 and a subdued Q2, with this acquisition we remain confident of achieving a 10-15% revenue growth over US$ 215m reported in the US for FY21 We now have sufficient approved products that will enable us to achieve our target of US$ 400m in our phase 1 for the US markets over 24 months

View entire presentation